SHOCK: FDA Delays Moderna Vax for Adolescents Citing Concern of Myocarditis Risk in Children

Sweden and Denmark announced last week they were halting Moderna COVID vaccinations for those under 30-years-old due to possible side effects.

This was very big news.
The two nations saw ample evidence to ban the vaccine for its youth.

Pfizer filed for FDA approval of the vaccine to children aged 5 to 11 ten days ago.

According to the VAERS tracking website, in the United States, 4,144 Americans have died following the Moderna COVID vaccination. 11,346 have died due to the Pfizer vaccination.

On Monday the FDA delayed approval for the Moderna vaccine for children.

The Examiner reported:

The U.S. Food and Drug Administration announced Friday it would delay its decision on administration of the Moderna vaccine to adolescents, citing concerns the shot may lead to a heightened risk of a rare heart condition.

The FDA has not yet determined if the risk is higher for adolescents, but the agency is planning to review the data further before extending the vaccine’s eligibility, according to the Wall Street Journal.

“I think people can be reassured that the risk of myocarditis with an mRNA vaccine is low, it appears to be balanced between the different products,” Paul Burton, Moderna’s chief medical officer, told the outlet.